Reviva Pharmaceuticals Stock (NASDAQ: RVPH) stock price, news, charts, stock research, profile.
Open | $1.37 |
Close | - |
Volume / Avg. | 211.07K / 464.94K |
Day Range | $1.23 - $1.37 |
52 Wk Range | 0.60 - 6.80 |
Market Cap | $41.86M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 22.93% |
Days to Cover | 4.75 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Reviva Pharmaceuticals (NASDAQ:RVPH) through any online brokerage.
Other companies in Reviva Pharmaceuticals’s space includes: Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP) and Rani Therapeutics Hldgs (NASDAQ:RANI).
Reviva Pharmaceuticals has a consensus price target of $14.80.
The stock price for Reviva Pharmaceuticals (NASDAQ: RVPH) is $1.265 last updated September 23, 2024 at 3:49 PM EDT.
There are no upcoming dividends for Reviva Pharmaceuticals.
Reviva Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Reviva Pharmaceuticals.
Reviva Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.